ITCI
Intra-Cellular Therapies Inc.
ITCI
ITCI
Delisted
ITCI was delisted on the 1st of April, 2025.
282 hedge funds and large institutions have $4.38B invested in Intra-Cellular Therapies Inc. in 2022 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 94 increasing their positions, 94 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
20% less call options, than puts
Call options by funds: $16.9M | Put options by funds: $21M
Holders
282
Holding in Top 10
6
Calls
$16.9M
Puts
$21M
Top Buyers
| 1 | +$93.1M | |
| 2 | +$69.3M | |
| 3 | +$25.3M | |
| 4 |
BlackRock
New York
|
+$18.4M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$13.3M |
Top Sellers
| 1 | -$59.9M | |
| 2 | -$47.5M | |
| 3 | -$26.6M | |
| 4 |
SC
Samlyn Capital
New York
|
-$25M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$24.4M |